Designation based on clinical evidence indicating INO-3107 may demonstrate substantial improvement over existing therapies
• First Breakthrough Therapy designation for an INOVIO DNA medicine candidate
https://finance.yahoo.com/news/inovio-announces-u-fda-breakthrough-120000300.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.